Curesponse Israeli Company

Curesponse’s technology represents the next step in personalized cancer medicine, advancing prediction capabilities beyond genomics to understand how cancer treatments will affect the patient’s tumor cells when they are in their native tumor.

Health Tech & Life Sciences Biotechnology Health Care Medical Medical Device

Alternatives

No alternatives listed yet.

AI-Generated Alternatives

AI is thinking and generating alternatives...

Suggest an Alternative

Name *

URL *

Founders

Guy Neev

Seth Salpeter

Parent Companies/Investors

aMoon Fund

NCL Technology Ventures

Office Locations

London, United Kingdom

Rehovot, Israel

References

[1]

finder.startupnationcentral.org - https://finder.startupnationcentral.org/company_page/curesponse

[2]

crunchbase.com - https://www.crunchbase.com/organization/curesponse

External links are provided for reference and verification purposes.